Diagnosing the decline in pharmaceutical R&D efficiency

  title={Diagnosing the decline in pharmaceutical R&D efficiency},
  author={J. Scannell and Alex Blanckley and Helen Boldon and B. Warrington},
  journal={Nature Reviews Drug Discovery},
  • J. Scannell, Alex Blanckley, +1 author B. Warrington
  • Published 2012
  • Business, Medicine
  • Nature Reviews Drug Discovery
  • The past 60 years have seen huge advances in many of the scientific, technological and managerial factors that should tend to raise the efficiency of commercial drug research and development (R&D). Yet the number of new drugs approved per billion US dollars spent on R&D has halved roughly every 9 years since 1950, falling around 80-fold in inflation-adjusted terms. There have been many proposed solutions to the problem of declining R&D efficiency. However, their apparent lack of impact so far… CONTINUE READING
    1,152 Citations

    Figures and Topics from this paper

    Explore Further: Topics Discussed in This Paper

    When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis
    • 116
    • PDF
    The endless frontier? The recent increase of R&D productivity in pharmaceuticals
    • 5
    • PDF
    Drug discovery goes back to school: changing ecosystem of drug discovery and the rising role of academia
    • B. Slusher
    • Political Science, Medicine
    • Journal of the peripheral nervous system : JPNS
    • 2014
    • 2
    Changing R&D models in research-based pharmaceutical companies
    • 136
    A Ricardian-Demand Explanation for Changing Pharmaceutical R&D Productivity
    • PDF
    Discontinued drugs in 2012: cardiovascular drugs
    • 4
    Scientific real-time research problem-solving and pharmaceutical innovation
    • 4
    • Highly Influenced


    The productivity crisis in pharmaceutical R&D
    • 670
    • PDF
    Rebuilding the R&D engine in big pharma.
    • 239
    How to improve R&D productivity: the pharmaceutical industry's grand challenge
    • 2,313
    • PDF
    Why has R&D productivity declined in the pharmaceutical industry?
    • 30
    • A. Smith
    • Business, Medicine
    • Dental student
    • 1965
    • 105
    • PDF
    Identifying R&D outliers
    • 18
    Lessons from 60 years of pharmaceutical innovation
    • B. Munos
    • Medicine
    • Nature Reviews Drug Discovery
    • 2009
    • 934
    • PDF
    A closer look at the returns and risk of pharmaceutical R&D.
    • 40